Lawmaker asks watchdog to check TrumpRx drug savings claims
Frank Pallone requested a Government Accountability Office review of TrumpRx financial benefits on October 27.
Request for official investigation
House ranking member Frank Pallone sent a letter to the Government Accountability Office. He asked the agency to examine whether the White House platform actually saved money for Americans. The inquiry follows administration claims that the site provided significant financial relief since its February launch.
Questions about missing data
Pallone stated the government failed to disclose key information needed to evaluate the platform. He specifically pointed out a lack of details regarding most-favored nation agreements with drugmakers. Without these records, it is difficult to determine if any meaningful financial benefit occurred.
Nature of the service
The TrumpRx website directs consumers to coupons or links for discounts rather than selling drugs. Pallone noted that the administration has made sweeping statements about the savings achieved. The lawmaker wants independent verification before accepting these assertions as fact.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.